SCHEMBL4265764

SCHEMBL4265764

CCOC(=O)c1sc(N)cc1-c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.63
MAPT P10636 8/20 0.63
HPGD P15428 8/20 0.63
MEN1 O00255 6/20 0.63
KMT2A Q03164 6/20 0.63
RAB9A P51151 5/20 0.63
HSD17B10 Q99714 4/20 0.63
KDM4E B2RXH2 4/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
NPC1 O15118 3/20 0.63
GAA P10253 3/20 0.58
MAPK1 P28482 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ALOX15 P16050 1/20 0.56
CDC7 O00311 3/20 0.52
DBF4 Q9UBU7 3/20 0.52
GRM6 O15303 2/20 0.52
TRPM8 Q7Z2W7 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5066590 0.86 PRKCZ (0.57) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7264963 0.80 GRM6 (0.51) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL1886283 0.78 MAPT (0.57) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4259827 0.78 RORB (0.49) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL14234474 0.77 ALDH1A1 (0.59) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL1882680 0.77 MAPT (1.00) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL244336 0.77 ALOX15 (0.58) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4262602 0.76 ALDH1A1 (0.49) ALDH1A1MAPTHPGDMEN1KMT2A
Hydrochloric Acid SCHEMBL244320 0.75 ALOX15 (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL3256879 0.75 BCAT2 (0.57) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048258-A1 Amide Compound TAKEDA, PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-19 US disclosed
US-20090048258-A1 Amide Compound TAKEDA, PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-19 US disclosed
EP-1845081-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048258-A1 Amide Compound DLAT, DGAT1, DGAT2 ALDH1A1 435/4885MAPT 3900/4885HPGD 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.